ACD/Labs has launched MetaSense, an automated metabolite identification platform. It combines comprehensive metabolic transformation prediction with analysis of LC-MS analytical measurements to identify, visualise and report chemical biotransformations. It is built on the ACD/Spectrus platform and provides knowledge management capabilities that allow the information from metabolite studies to be applied in other areas of R&D. The live data environment and new web-based visalisation components help decision support and knowledge sharing.